CFCarla Santana Francisco

Carla Santana Francisco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carla Santana Francisco has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • State-of-Art on the Synthesis of Heterocyclic Compounds Targeting SARS-CoV-2

    by Pedro Alves Bezerra Morais, Jessica Adalgisa Barbosa Silva, Clara Lirian Javarini, Caroline de Souza Fontes Gaspari, Ramon Ramires Trancoso Bottocim, Thays Cardoso Valim, Carla Santana Francisco, Alvaro Cunha Neto, Valdemar Lacerda Junior

    The Corona virus disease-19 (COVID-19) pandemic challenged the scientific community in the search for developing effective treatments, such as medicine and/or a vaccine candidate. The SARS-CoV-2 virus and its variants, Omega, Omicron, and Delta, remain as a major threat to human health, causing significant morbidity and mortality worldwide. Given that computational methods are thought to be quick, easy, and inexpensive, they have been widely used in this scenario to design new anti-COVID-19 drug candidates. In addition, heterocyclic scaffolds have been explored exhaustively for their biological properties and as fruitful sources of new molecular entities to fulfill the chemical space available.In light of this, we intend to highlight the synthetic techniques used to produce novel heterocyclic derivatives that may serve as effective anti-COVID-19 lead candidates by focusing on important viral proteins and using computational tools. Then, the objective of this article, with a theoretical nature, is to contribute to the delimitation of organic chemistry methods to achieve new anti- COVID-19 agents.


  • Open Access

    Coumarin/β-Cyclodextrin Inclusion Complexes Promote Acceleration and Improvement of Wound Healing

    by Flávia Viana Avelar Dutra, Carla Santana Francisco, Bruna Carneiro Pires, Marcella Matos Cordeiro Borges, Ana Luiza Horta Torres, Vivian Alexandra Resende, Marcella Fernandes Mano Mateus, Daniel Fernandes Cipriano, Flávio Bastos Miguez, Jair Carlos Checon de Freitas, et al.

    Coumarins have great pharmacotherapeutic potential, presenting several biological and pharmaceutical applications, like antibiotic, fungicidal, anti-inflammatory, anticancer, anti-HIV, and healing activities, among others. These molecules are practically insoluble in water, and for biological applications, it became necessary to complex them with cyclodextrins (CDs), which influence their bioavailability in the target organism. In this work, we studied two coumarins, and it was possible to conclude that there were structural differences between 4,7-dimethyl-2H-chromen-2-one (DMC) and 7-methoxy-4-methyl-2H-chromen-2-one (MMC)/β-CD that were solubilized in ethanol, frozen, and lyophilized (FL) and the mechanical mixtures (MM). In addition, the inclusion complex formation improved the solubility of DMC and MMC in an aqueous medium. According to the data, the inclusion complexes were formed and are more stable at a molar ratio of 2:1 coumarin/β-CD, and hydrogen bonds along with π-π stacking interactions are responsible for the better stability, especially for (MMC)2@β-CD. In vivo wound healing studies in mice showed faster re-epithelialization and the best deposition of collagen with the (DMC)2@β-CD (FL) and (MMC)2@β-CD (FL) inclusion complexes, demonstrating clearly that they have potential in wound repair. Therefore, (DMC)2@β-CD (FL) deserves great attention because it presented excellent results, reducing the granulation tissue and mast cell density and improving collagen remodeling. Finally, the protein binding studies suggested that the anti-inflammatory activities might exert their biological function through the inhibition of MEK, providing the possibility of development of new MEK inhibitors.


  • Triazole: A New Perspective in Medicinal Chemistry and Material Science

    by Pedro Alves Bezerra Morais, Clara Lirian Javarini, Thays Cardoso Valim, Carla Santana Francisco, Lara Chaves de Freitas Ferreira, Ramon Ramires Trancoso Bottocim, Álvaro Cunha Neto, Valdemar Lacerda Júnior

    Triazole, which can exist in two isomeric forms: 1,2,3- and 1,2,4-triazole, is considered to be a privileged scaffold with recognized biological and pharmaceutical potential. Furthermore, due to their physicochemical properties, the applications of triazoles have been explored in fields ranging from medicinal chemistry to materials science. Triazoles have not only drawn the attention of the scientific community for all the aforementioned properties but also due to their ability to be incorporated into other bioactive and functional molecules. The connection between two pharmacophores makes it possible to potentiate specific biological activities or add different properties. Interest in the compatibility of the triazole nucleus with peptide structures is highlighted in the development of new therapeutic targets. In epigenetics, triazole is linked to various compounds that are used in the creation of new drugs that could potentially inhibit histone-modifying enzymes. Other new and potentially more effective materials that can take advantage of a triazole moiety include light-emitting diodes and solar cells, among others. Hence, we propose a novel approach to the promising applications of triazolic ring, a compound that has been gaining prominence in organic chemistry due to its applicability to many different fields.


  • Evaluation of Powdered Chia Mucilage as an Iron Ore Dust Suppressor and Use of Chia Oil, Unfit for Consumption, in the Production of Biodiesel

    by Lucas de Almeida Gama, Carolini Spadetto, Carla Santana Francisco, Sergio Henriques Saraiva, Eloi Alves da Silva Filho


  • Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition

    by Rayssa Ribeiro, Mariana A. Eloy, Carla S. Francisco, Clara L. Javarini, Gabriela M. Ayusso, Victor Da Rocha Fonseca, Wanderson Romão, Luis O. Regasini, Sheila C. Araujo, Michell O. Almeida, et al.

    Background: Natural products have been universally approached in the research of novel trends useful to detail the essential paths of the life sciences and as a strategy for pharmacotherapeutics. Objective: This work focuses on further modification to the 6-hydroxy-flavanone building block aiming to obtain improved BCR-ABL kinase inhibitors. Methods: Ether derivatives were obtained from Williamson synthesis and triazole from Microwave- assisted click reaction. Chemical structures were finely characterized through IR, 1H and 13C NMR and HRMS. They were tested for their inhibitory activity against BCR-ABL kinase. Results: Two inhibitors bearing a triazole ring as a pharmacophoric bridge demonstrated the strongest kinase inhibition at IC50 value of 364 nM (compound 3j) and 275 nM (compound 3k). Conclusion: 6-hydroxy-flavanone skeleton can be considered as a promising core for BCR-ABL kinase inhibitors.


  • Semisynthetic Triazoles as an Approach in the Discovery of Novel Lead Compounds

    by Pedro Alves Bezerra Morais, Carla Santana Francisco, Heberth de Paula, Rayssa Ribeiro, Mariana Alves Eloy, Clara Lirian Javarini, Álvaro Cunha Neto, Valdemar Lacerda Júnior

    Historically, medicinal chemistry has been concerned with the approach of organic chemistry for new drug synthesis. Considering the fruitful collections of new molecular entities, the dedicated efforts for medicinal chemistry are rewarding. Planning and search for new and applicable pharmacologic therapies involve the altruistic nature of the scientists. Since the 19th century, notoriously applying isolated and characterized plant-derived compounds in modern drug discovery and various stages of clinical development highlight its viability and significance. Natural products influence a broad range of biological processes, covering transcription, translation, and post-translational modification, being effective modulators of most basic cellular processes. The research of new chemical entities through “click chemistry” continuously opens up a map for the remarkable exploration of chemical space towards leading natural products optimization by structure-activity relationship. Finally, in this review, we expect to gather a broad knowledge involving triazolic natural product derivatives, synthetic routes, structures, and their biological activities.


  • Suppression of Iron Ore Particulate Matter Using Chia Mucilage

    by Lucas de Almeida Gama, Carolini Spadetto, Carla Santana Francisco, Eloi Alves da Silva Filho


  • Restricted access macroporous magnetic polyaniline for determination of coumarins in rat plasma

    by Flávia Viana Avelar Dutra, Bruna Carneiro Pires, Monique Macedo Coelho, Raquel Alves Costa, Carla Santana Francisco, Valdemar Lacerda, Keyller Bastos Borges


  • Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition

    by Carla S. Franciscoa, Clara L. Javarini, Iatahanderson de S. Barcelos, Pedro A. B. Morais, Heberth de Paula, Warley de S. Borges, Álvaro Cunha Neto, Valdemar Lacerda

    Background: Glycogen synthase kinase-3 (GSK-3) is involved in the phosphorylation and inactivation of glycogen synthase. GSK-3 inhibitors have been associated with a variety of diseases, including Alzheimer´s disease (AD), diabetes type II, neurologic disorders, and cancer. The inhibition of GSK-3β isoforms is likely to represent an effective strategy against AD. Objective: The present work aimed to design and synthesize coumarin derivatives to explore their potential as GSK-3β kinase inhibitors. Method: The through different synthetic methods were used to prepare coumarin derivatives. The GSK-3β activity was measured through the ADP-Glo™ Kinase Assay, which quantifies the kinasedependent enzymatic production of ADP from ATP, using a coupled-luminescence-based reaction. A docking study was performed by using the crystallographic structure of the staurosporine/GSK-3β complex [Protein Data Bank (PDB) code: 1Q3D]. Results: The eleven coumarin derivatives were obtained and evaluated as potential GSK-3β inhibitors. Additionally, in silico studies were performed. The results revealed that the compounds 5c, 5d, and 6b inhibited GSK-3β enzymatic activity by 38.97–49.62% at 1 mM. The other coumarin derivatives were tested at 1 mM, 1 µM, and 1 nM concentrations and were shown to be inhibitor candidates, with significant IC50 (1.224–6.875 µM) values, except for compound 7c (IC50 = 10.809 µM). Docking simulations showed polar interactions between compound 5b and Lys85 and Ser203, clarifying the mechanism of the most potent activity. Conclusion: The coumarin derivatives 3a and 5b, developed in this study, showed remarkable activity as GSK-3β inhibitors.


  • Synthetic Methods Applied in the Preparation of Coumarin-based Compounds

    by Cristina S. Francisco, André F. Constantino, Álvaro Cunha Neto, Valdemar Lacerda

    Coumarins (2H-chromen-2-ones) are heterocyclic compounds of wide scientific interest due to their important biological and pharmaceutical properties such as antitumor, antioxidant, anti-inflammatory and antimicrobial activities as well as enzymatic inhibitors related to neurodegenerative diseases. Due to their structural variability, this compound class has been attracting considerable interest in the natural products and synthetic organic chemistry areas. Coumarins and their derivatives have been prepared by a variety of methods, including Perkin, Wittig and Reformatsky reactions, Pechmann and Knoevenagel condensations, and Claisen rearrangement, among others. In the present review we report the different synthetic methods used in the preparation of coumarin derivatives exploited in the last ten years (from 2008 to 2018), regarding the research demand for new structural scaffolds.